Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Melanoma prevalently occurs on parts of the body that have been overexposed to the sun. However, it can also originate in the nervous system, eye and mucous membranes. Melanoma has been thought for a long time to arise through a series of genetic mechanisms involving numerous irreversible changes within the human genome. However, recently, “epimutations” have attracted considerable attention owing to their high prevalence rate and reversible nature. These observations opened up new perspectives in the use of epidrugs with the potential for restoring the “correct” control of neoplastic genomes. Here, we focused on the common consensus on genetics and epigenetics in melanoma. We also discussed the clinical applications of regulators of epigenetic enzymes able to revert the epigenetic and metabolic hallmarks of melanoma cells. Such anti-neoplastic agents affect the expression profile of antioncogenes, proto-oncogenes, and microRNAs resulting in enhanced differentiation, apoptosis, and growth inhibition.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520615666150803124139
2016-05-01
2025-01-09
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520615666150803124139
Loading

  • Article Type:
    Research Article
Keyword(s): Cutaneous melanoma; epigenetics; genetics; mucosal melanoma; uveal melanoma
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test